Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function
Paolo Milani, Marco Basset, Paola Curci, Andrea Foli, Rita Rizzi, Mario Nuvolone, R. Guido, Loreto Gesualdo, Giorgina Specchia, Giampaolo Merlini, Giovanni Palladini
Abstract
Key Points Daratumumab is effective in treated light chain deposition disease. Daratumumab can prevent progression of renal failure in these patients.
Topics & Concepts
DaratumumabRenal functionMedicineKidney diseaseKidneyImmunoglobulin light chainDiseaseInternal medicineImmunologyMultiple myelomaAntibodyLenalidomideAmyloidosis: Diagnosis, Treatment, OutcomesRenal Diseases and GlomerulopathiesMyeloproliferative Neoplasms: Diagnosis and Treatment